Skip to main content
. 2021 Feb 12;114(3):182–189. doi: 10.1093/qjmed/hcab029

Table 1.

Baseline characteristics

Variable M (SD) or frequency (%) Whole sample (n = 355) M (SD) or frequency (%) Mild/ moderate (n = 144) M (SD) or frequency (%) Severe/ very severe (n = 94) M (SD) or frequency (%) Critical (n = 117) P-value
Demographics
 Age (years) 84.3 (6.51) 84.2 (6.54) 85.8 (6.69) 83.2 (6.15) 0.02
 Female gender 164 (46.2) 69 (47.9) 46 (48.9) 49 (41.9) 0.51

 Race

  White

  Black

  Asian

  Other

239 (67.3)

45 (12.7)

41 (11.5)

30 (8.5)

99 (68.8)

21 (14.6)

12 (8.3)

12 (8.3)

58 (61.7)

13 (13.8)

16 (17.0)

7 (7.4)

82 (70.1)

11 (9.4)

13 (11.1)

11 (9.4)

0.41

 Ethnicity

  Non-Hispanic

  Hispanic

  Unknown

323 (91.0)

27 (7.6)

5 (1.4)

131 (91.0)

12 (8.3)

1 (0.7)

88 (93.6)

6 (6.4)

0 (0.0)

104 (88.9)

9 (7.7)

4 (3.4)

0.35
Comorbidities
 Obesity 56 (15.8) 16 (14.2) 12 (14.6) 28 (26.4) 0.04

 Smoking

  Never

  Active

  Former

  Unknown

94 (26.5)

6 (1.7)

30 (8.5)

225 (63.4)

38 (26.4)

4 (2.8)

12 (8.3)

90 (62.5)

20 (21.3)

0 (0.0)

8 (8.5)

66 (70.2)

36 (31.0)

2 (1.7)

10 (8.6)

69 (59.0)

0.52
 Hypertension 279 (78.6) 108 (75.5) 74 (78.7) 97 (82.9) 0.35
 Diabetes mellitus 120 (33.8) 49 (34.3) 30 (31.9) 41 (35.0) 0.89
 Cerebrovascular accident 37 (10.4) 9 (6.3) 13 (13.8) 15 (12.8) 0.11
 Atrial fibrillation 78 (22.0) 25 (17.5) 23 (24.5) 30 (25.6) 0.23
 Heart failure 93 (26.2) 35 (26.1) 25 (28.1) 33 (30.6) 0.75
 Chronic obstructive pulmonary disease 34 (9.6) 14 (9.8) 11 (11.7) 9 (7.7) 0.61
 Asthma 14 (3.9) 4 (2.8) 5 (5.3) 5 (4.3) 0.62
 Deep vein thrombosis/pulmonary embolism 17 (4.8) 7 (4.9) 4 (4.3) 6 (5.1) 0.77
 Chronic kidney disease 25 (7.0) 9 (6.3) 6 (6.4) 10 (8.5) 0.75
 Coronary artery disease 93 (26.2) 41 (28.7) 21 (22.3) 31 (26.5) 0.56

 Cancer

  No

  Active treatment

  Past 5 years

316 (89.0)

17 (4.8)

21 (5.9)

123 (86.0)

11 (7.7)

9 (6.3)

84 (89.4)

6 (6.4)

4 (4.3)

109 (93.2)

0 (0.0)

8 (6.8)

0.01
 Dementia 88 (24.8) 27 (18.9) 39 (41.5) 22 (18.8) <0.001
Presenting symptoms
 Fever 177 (49.9) 64 (45.1) 52 (55.3) 61 (52.1) 0.27
 Cough 146 (41.1) 57 (40.1) 34 (36.2) 55 (47.4) 0.24
 Anosmia 1 (0.3) 0 (0.0) 0 (0.0) 1 (0.9) 0.60
 Ageusia 3 (0.8) 1 (0.7) 2 (2.1) 0 (0.0) 0.27
 Myalgia 34 (9.6) 15 (10.6) 4 (4.3) 15 (12.8) 0.10
 Nausea 16 (4.5) 9 (6.3) 4 (4.3) 3 (2.6) 0.34
 Vomiting 14 (3.9) 9 (6.4) 4 (4.3) 1 (0.9) 0.06
 Diarrhea 24 (6.8) 10 (7.0) 9 (9.6) 5 (4.3) 0.31
 Shortness of breath 209 (58.9) 59 (41.5) 65 (69.1) 85 (72.6) <0.001
 Chest pain 18 (5.1) 8 (5.6) 6 (6.4) 4 (3.4) 0.56
Vital signs
 Systolic blood pressure [mmHg] 129.6 (24.68) 129.9 (22.53) 129.0 (24.62) 129.6 (27.30) 0.96
 Diastolic blood pressure [mmHg] 73.7 (19.07) 74.0 (16.82) 74.0 (19.90) 73.0 (21.00) 0.90
 Heart rate [per minute] 93.8 (21.68) 91.1 (20.39) 95.4 (19.86) 95.9 (24.27) 0.15
 Oxygen saturation 91.7 (8.08) 94.3 (5.47) 89.6 (9.52) 90.3 (8.67) <0.001
 Respiratory rate [per minute] 24.7 (7.19) 21.4 (4.00) 26.3 (7.82) 27.3 (8.14) <0.001

Note: Mm mean; SD, standard deviation. Sample size for continuous variables less than 355 are: systolic blood pressure (n = 353), diastolic blood pressure (n = 353), heart rate (n = 352), oxygen saturation (n = 351) and respiratory rate (n = 353). Sample size for categorical variables missing are: obesity (n = 54), hypertension (n = 1), diabetes mellitus (n = 1), cerebrovascular accident (n = 1), atrial fibrillation (n = 1), heart failure (n = 24), chronic obstructive pulmonary disease (n = 1), chronic kidney disease (n = 2), asthma (n = 1), deep vein thrombosis/pulmonary embolism (n = 2), coronary artery disease (n = 1), cancer (n = 1), dementia (n = 1), fever (n = 2), cough (n = 3), anosmia (n = 3), ageusia (n = 2), myalgia (n = 3), nausea (n = 2), vomiting (n = 3), diarrhea (n = 2), shortness of breath (n = 2) and chest pain (n = 2).